Risposta tardiva alla terapia con Omalizumab in paziente con asma allergico grave persistente

Translated title of the contribution: Late response to Omalizumabin a patient with severe persistent allergic asthma

F. Menzella, C. Carbonelli, A. Roggeri, L. Zucchi

Research output: Contribution to journalArticle

Abstract

A patient suffering with severe asthma (accompanied with allergic oculorhinitis), which, despite multidrug therapy and oral steroids (with consequent osteoporosis), was anyway obliged to several hospitalisations and rescues. Omalizumab was added-on and used during several months without appreciable results. Its therapeutic activity appeared only after eighth months of treatment, following this time only giving rise to clinical and functional improvement and better quality of life. The possibility of apparent "non responders" (in the facts "late responders") to omalizumab has to be taken into the highest consideration.

Translated title of the contributionLate response to Omalizumabin a patient with severe persistent allergic asthma
Original languageItalian
Pages (from-to)308-310
Number of pages3
JournalGIMT - Giornale Italiano delle Malattie del Torace
Volume60
Issue number5
Publication statusPublished - 2006

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Late response to Omalizumabin a patient with severe persistent allergic asthma'. Together they form a unique fingerprint.

  • Cite this